Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).
|Articles|March 27, 1996
Swissray gets NASDAQ small-cap listing
The stock of x-ray digitization firm Swissray International hasbeen approved for listing on the NASDAQ stock exchange's small-capbulletin board under the symbol SRMI. Swissray, of Hitzkirch,Switzerland, is developing Add-On Bucky, a device that
Advertisement
The stock of x-ray digitization firm Swissray International has
been approved for listing on the NASDAQ stock exchange's small-cap
bulletin board under the symbol SRMI. Swissray, of Hitzkirch,
Switzerland, is developing Add-On Bucky, a device that retrofits
to conventional x-ray systems for x-ray digitization (SCAN 12/13/95).
Swissray's stock was trading at about $4.75 a share last week.
Advertisement
Related to this article
Catch up on the most-well viewed radiology content in October 2026.
In the second of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, discussed the possible impact of new research showing significant declines in CT radiation dosing over the past decade, future research directions and the potential for indication-based diagnostic reference levels (DRLs) in the future.
Emerging research suggests that the benefits of photon-counting CT may be more pronounced in patients with obesity.
Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.
In the first of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, reviewed key findings from a study examining CT radiation dosing over the past decade and shared insights from their experience for ensuring optimal radiation dosing for CT scans.
In a new webinar program, Raj Chopra, MD and Peter Reilly share their insights on the importance of cybersecurity, keys to effective downtime communication, the ripple effects and costs of security breaches, challenges with AI and practical safeguards.
The AI-powered NeuroDR software reportedly removes bone, soft tissue and veins from CTA scans and provides subsequent 3D MIP views and curved planar reformatted views of carotid and vertebral arteries.
Advertisement
Advertisement